Cart (0)
  • No items in cart.
Total
$0
There is a technical issue about last added item. You can click "Report to us" button to let us know and we resolve the issue and return back to you or you can continue without last item via click to continue button.
Search book title
Filters:
FORMAT
BOOKS
PACKAGES
EDITION
to
PUBLISHER
(1)
(338)
(589)
(599)
(55)
(234)
(1006)
(690)
(2183)
(117)
(95207)
(63)
(575)
(124)
(33)
(21)
(20)
(95391)
(3)
(17)
(1)
(374)
(322)
(6938)
(241)
(21)
(6)
(1667)
(17)
(19)
(28)
(4)
 
(6)
(7)
(115)
(3)
(57)
(5)
(5)
(1)
(1)
(2)
(25)
(27)
(27)
(13)
(61)
(24)
(22)
(7)
(8)
(20)
(1)
(3)
(50)
(6)
(33)
CONTENT TYPE
 Act
 Admin Code
 Announcements
 Bill
 Book
 CADD File
 CAN
 CEU
 Charter
 Checklist
 City Code
 Code
 Commentary
 Comprehensive Plan
 Conference Paper
 County Code
 Course
 DHS Documents
 Document
 Errata
 Executive Regulation
 Federal Guideline
 Firm Content
 Guideline
 Handbook
 Interpretation
 Journal
 Land Use and Development
 Law
 Legislative Rule
 Local Amendment
 Local Code
 Local Document
 Local Regulation
 Local Standards
 Manual
 Model Code
 Model Standard
 Notice
 Ordinance
 Other
 Paperback
 PASS
 Periodicals
 PIN
 Plan
 Policy
 Product
 Product - Data Sheet
 Program
 Provisions
 Requirements
 Revisions
 Rules & Regulations
 Standards
 State Amendment
 State Code
 State Manual
 State Plan
 State Standards
 Statute
 Study Guide
 Supplement
 Sustainability
 Technical Bulletin
 All
  • BSI
    PAS 93:2011 Characterization of human cells for clinical applications. Guide
    Edition: 2011
    $151.82
    / user per year

Description of PAS 93:2011 2011

This PAS gives guidance on the characterization of human cells being developed for clinical applications.

This PAS is not a regulatory guideline, but gives guidance on the need for characterization of cells and key current, available cell characterization techniques. The choice of characterization techniques needs to be made by the developer on a case-by-case basis depending on the intended use of the cells.

This PAS covers the need for the characterization of cellular starting materials and cellular active substances and the characterization parameters (including identity, purity, cellular impurities, biological activity and viability).

This PAS is intended for use by organizations and individuals with an interest in the development of human cells for clinical applications including academic groups, small and medium sized enterprises (SMEs) and larger industrial manufacturers and the general public.

The guidance in this PAS is applicable to the characterization of human cells in the context of EU and US regulation of cell therapy products, but it will be broadly relevant to all regions/markets that accept or refer to International Conference on Harmonisation (ICH) guidance in the regulation of biological medicinal products including cell therapy products.

This PAS is not a manual for developing a cell therapy product and does not cover:

  1. complete characterization programmes;

  2. characterization of the manufacturing process;

  3. quality systems used to retain a state of control when carrying out characterization;

  4. safety testing of cells and cell therapy products; and

    NOTE Requirements for safety testing of cells and cell therapy products are addressed in detail in relevant legislation and guidance documents.

  5. xenografts, xenogeneic feeder cells, whole organ or bone marrow transplants and blood transfusions.



About BSI

BSI Group, also known as the British Standards Institution is the national standards body of the United Kingdom. BSI produces technical standards on a wide range of products and services and also supplies certification and standards-related services to businesses.

X